The findings showed that the fluorescence signal in brain tumors of glioma-bearing mice treated with Tf-ELE/CTX@BLIP was significantly lower compared with that of other groups after 15 days of treatment (Fig. 6A). This evidence concerns the gene TF and central nervous system cancer.